Activities

• 

  Mary Grace N. Tamio   

  on June 25 2022 at 07:29 PM Edited public

  Nivolumab in patients with relapsed or refractory peripheral T-cell lymphoma: modest activity and cases of hyperprogression
  
  #nivolumab #tcelllymphoma #hyperprogression #journals #articles
  
  For more information | ⬇️
  https://social.cn1699.cn/livenewss/news/608033/Nivolumab-in-patients-with-relapsed-or-refractory-peripheral-T-cell-lymphoma-modest-activity-and-cases-of-hyperprogression

  

  Nivolumab in patients with relapsed or refractory peripheral T-cell lymphoma: modest activity and cases of hyperprogression | CN1699 Social

  The social Community for Global Healthcare Elites. Doctors, Medical Professionals & Pharmaceutical professionals. Medical Thesis Abstracts and...
  0 0 0 0 0 0 0

  comment Comment

  thumb_upLike

  share Share